Onkos Surgical has announced that its patient-specific My3D pelvic implants, made from 3D-printed titanium alloy, have now been used in over 1,000 clinical procedures. Designed based on each patient's CT data and FDA-approved, the My3D series is a benchmark product in metal 3D-printed implants for limb-sparing orthopedic oncology. This milestone in real-world application validates the clinical value of titanium alloy powder bed fusion implants in terms of osseointegration and complex anatomical matching, marking a shift for metal 3D-printed implants from 'special cases' to 'routine treatment options.' For powder buyers, this signals several insights: ① Medical-grade titanium alloy powder (Ti-6Al-4V ELI) represents a high-margin niche in the powder industry, and the scaling of overseas benchmark products confirms genuine demand; ② Domestic orthopedic implant manufacturers are accelerating their customization efforts, making oxygen content and batch-to-batch stability key purchasing criteria for medical-grade powders; ③ It is advisable to monitor the approval progress of Class III medical device certifications from China's NMPA to seize the window for domestic medical powder substitution.